BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension
NCT02000856 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2018-03-27
Summary
The study is a single center randomised, double-blind, placebo-controlled crossover study to assess the effects of beetroot juice in patients with pulmonary arterial hypertension.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Beetroot juice
Sponsors & Collaborators
- collaborator OTHER
-
Uppsala University
lead OTHER
Principal Investigators
-
Gerhard Wikström, MD, PhD · Uppsala University and Uppsala University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2015-02-28
- Completion
- 2015-02-28
Countries
- Sweden
Study Locations
More Related Trials
-
A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension
NCT03657095 ·Status: TERMINATED ·Phase: PHASE3
-
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
NCT00990314 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)
NCT04968210 ·Status: COMPLETED
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
NCT00423202 ·Status: COMPLETED ·Phase: PHASE3
-
Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study
NCT03655704 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
NCT06137742 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Apabetalone for Pulmonary Arterial Hypertension
NCT04915300 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
NCT02725372 ·Status: TERMINATED ·Phase: PHASE3
-
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
NCT00989963 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH)
NCT01338636 ·Status: COMPLETED ·Phase: PHASE4
-
Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
NCT01847716 ·Status: TERMINATED
-
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT07073820 ·Status: RECRUITING ·Phase: PHASE2
-
Oxygen Treatment and Pulmonary Arterial Hypertension
NCT03683082 ·Status: UNKNOWN ·Phase: NA
-
6R-BH4 Pulmonary Arterial Hypertension Study
NCT00435331 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)
NCT02847260 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)
NCT06048120 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
NCT07218029 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
NCT00423748 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
NCT02736149 ·Status: TERMINATED ·Phase: PHASE2
-
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
NCT02885636 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)
NCT04813926 ·Status: COMPLETED
-
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)
NCT05649748 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension
NCT00313222 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)
NCT00810693 ·Status: COMPLETED ·Phase: PHASE3
-
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
NCT02576002 ·Status: COMPLETED